Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
172
Frequently Asked Questions
What is Market Cap of Voyager Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Voyager Therapeutics Inc market cap is $233.52M.
What is the 52-week high for Voyager Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Voyager Therapeutics Inc 52 week high is $8.28 as of September 16, 2025.
What is the 52-week low for Voyager Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Voyager Therapeutics Inc 52 week low is $2.65 as of September 16, 2025.
What is Voyager Therapeutics Inc stock price today?
Voyager Therapeutics Inc stock price today is $4.40.
What was Voyager Therapeutics Inc stock price yesterday?
Voyager Therapeutics Inc stock price yesterday was $4.21.
What is the PE ratio of Voyager Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Voyager Therapeutics Inc’s P/E ratio is -2.27.
What is the Price-to-Book ratio of Voyager Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Voyager Therapeutics Inc P/B ratio is 0.9567.
What is the 50-day moving average of Voyager Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Voyager Therapeutics Inc 50-day moving average is $3.48.
How many employess does Voyager Therapeutics Inc has?